Bellevue Group’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-340,264
| Closed | -$6.17M | – | 234 |
|
|
2020
Q3 | $6.17M | Sell |
340,264
-1,122,032
| -77% | -$20.4M | 0.09% | 122 |
|
|
2020
Q2 | $20M | Sell |
1,462,296
-1,741,948
| -54% | -$23.9M | 0.28% | 79 |
|
|
2020
Q1 | $45.8M | Buy |
3,204,244
+41,601
| +1% | +$595K | 0.89% | 32 |
|
|
2019
Q4 | $53.6M | Buy |
3,162,643
+52,732
| +2% | +$893K | 0.85% | 36 |
|
|
2019
Q3 | $47.9M | Buy |
3,109,911
+9,143
| +0.3% | +$141K | 0.89% | 32 |
|
|
2019
Q2 | $72.7M | Buy |
3,100,768
+2,596,357
| +515% | +$60.9M | 1.24% | 25 |
|
|
2019
Q1 | $14.3M | Buy |
504,411
+46,115
| +10% | +$1.31M | 0.79% | 43 |
|
|
2018
Q4 | $13.8M | Buy |
458,296
+39,800
| +10% | +$1.2M | 0.91% | 32 |
|
|
2018
Q3 | $14.7M | Buy |
418,496
+39,195
| +10% | +$1.37M | 0.93% | 38 |
|
|
2018
Q2 | $8.99M | Buy |
379,301
+330,502
| +677% | +$7.84M | 0.77% | 46 |
|
|
2018
Q1 | $1.25M | Buy |
+48,799
| New | +$1.25M | 0.12% | 102 |
|